YU55899A - Cox-2 selektivni karprofen za lečenje bola i zapaljenja kod pasa - Google Patents

Cox-2 selektivni karprofen za lečenje bola i zapaljenja kod pasa

Info

Publication number: YU55899A
Authority: YU; Yugoslavia
Prior art keywords: cox; activity; acids; dogs; inhibition
Prior art date: 1997-05-05

Application number

YU55899A

Other languages

English (en)

Serbo-Croatian (sh)

Inventor

Kristin Marie Lundy

Anthony Paul Ricketts

Original Assignee

Pfizer Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-05-05

Filing date

1998-05-01

Publication date

2003-08-29

1998-05-01 Application filed by Pfizer Inc. filed Critical Pfizer Inc.

2003-08-29 Publication of YU55899A publication Critical patent/YU55899A/sh

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Medicinal Preparation (AREA)

YU55899A 1997-05-05 1998-05-01 Cox-2 selektivni karprofen za lečenje bola i zapaljenja kod pasa YU55899A (sh)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US4563597P	1997-05-05	1997-05-05

Publications (1)

Publication Number	Publication Date
YU55899A true YU55899A (sh)	2003-08-29

Family

ID=21939053

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
YU55899A YU55899A (sh)	1997-05-05	1998-05-01	Cox-2 selektivni karprofen za lečenje bola i zapaljenja kod pasa

Country Status (32)

Country	Link
EP (1)	EP0988034A1 (es)
JP (1)	JP2000513020A (es)
KR (2)	KR20010012300A (es)
CN (1)	CN1255059A (es)
AP (1)	AP9801234A0 (es)
AR (2)	AR011726A1 (es)
AU (1)	AU6932198A (es)
BG (1)	BG103852A (es)
BR (1)	BR9808720A (es)
CA (1)	CA2288759A1 (es)
DZ (1)	DZ2479A1 (es)
EA (1)	EA003696B1 (es)
GT (1)	GT199800063A (es)
HR (1)	HRP980244A2 (es)
HU (1)	HUP0001286A3 (es)
ID (1)	ID21311A (es)
IL (1)	IL132570A0 (es)
IS (1)	IS5220A (es)
MA (1)	MA26491A1 (es)
NO (1)	NO995389L (es)
NZ (1)	NZ500183A (es)
OA (1)	OA11213A (es)
PA (1)	PA8450601A1 (es)
PE (1)	PE72599A1 (es)
PL (1)	PL337003A1 (es)
SK (1)	SK148199A3 (es)
TN (1)	TNSN98059A1 (es)
TW (1)	TW590773B (es)
UY (1)	UY24989A1 (es)
WO (1)	WO1998050033A1 (es)
YU (1)	YU55899A (es)
ZA (1)	ZA983722B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6245797B1 (en)	1997-10-22	2001-06-12	Merck & Co., Inc.	Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
US6506785B2 (en) *	1998-05-22	2003-01-14	Pfizer, Inc.	Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
AU2003204888B2 (en) *	1998-05-22	2005-07-28	Pfizer Products Inc.	Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
EP1123091A1 (en) *	1998-10-23	2001-08-16	Merck Frosst Canada & Co.	Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
EP1637137A3 (en) *	1999-03-10	2006-07-05	G.D. Searle LLC	Method and composition for administering a cyclooxygenase-2 inhibitor to animals
WO2001034204A1 (en) *	1999-11-11	2001-05-17	Eli Lilly And Company	Oncolytic combinations for the treatment of cancer
JP2004521856A (ja) *	2000-05-15	2004-07-22	メルクフロストカナダアンドカンパニー	Ｃｏｘ−２選択的阻害剤およびトロンボキサン阻害剤を用いる併用療法ならびにそのための組成物
CA2411960C (en)	2000-06-13	2010-10-12	Wyeth	Analgesic and anti-inflammatory compositions containing cox-2 inhibitors
DE10032132A1 (de) *	2000-07-01	2002-01-17	Lohmann Therapie Syst Lts	Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
EP1307538B1 (en)	2000-08-07	2009-01-07	Vanderbilt University	Detection of cox-2 activity and anandamide metabolites
WO2003007875A2 (en) *	2001-07-16	2003-01-30	Hoegestaett Edward	Compounds with analgesic, antipyretic and/or anti-inflammatory activity
DK1534305T3 (da)	2003-05-07	2007-02-05	Osteologix As	Behandling af brusk-/knoglelidelser med vandoplöselige strontiumsalte
CA2533101A1 (en) *	2003-07-31	2005-02-03	Pharmacia & Upjohn Company Llc	Dispersible formulation of an anti-inflammatory agent
US20080269310A1 (en) *	2005-05-20	2008-10-30	Adrian Paul Foster	Synergistic Combinations
DK2079456T3 (da)	2007-04-04	2013-03-18	Sigmoid Pharma Ltd	Farmaceutiske cyclosporinsammensætninger
EP2061587A1 (en)	2007-04-26	2009-05-27	Sigmoid Pharma Limited	Manufacture of multiple minicapsules
BRPI1012196B1 (pt)	2009-05-18	2021-11-30	Sublimity Therapeutics Limited	Composição compreendendo gotas de óleo
EP2464341B1 (en)	2009-08-12	2022-07-06	Sublimity Therapeutics Limited	Immunomodulatory compositions comprising a polymer matrix and an oil phase
GB201020032D0 (en)	2010-11-25	2011-01-12	Sigmoid Pharma Ltd	Composition
GB201212010D0 (en)	2012-07-05	2012-08-22	Sigmoid Pharma Ltd	Formulations
GB201319791D0 (en)	2013-11-08	2013-12-25	Sigmoid Pharma Ltd	Formulations
ES2907285T3 (es)	2014-03-06	2022-04-22	Elanco Animal Health Incorporated	Composiciones de grapiprant y procedimientos de uso de las mismas
US12109218B2 (en)	2014-12-09	2024-10-08	Aratana Therapeutics, Inc.	Compositions of grapiprant and methods for using the same
KR20170102223A (ko)	2014-11-07	2017-09-08	시그모이드 파마 리미티드	사이클로스포린을 포함하는 조성물
CA2972996A1 (en) *	2015-01-09	2016-07-14	Jaguar Animal Health	Methods of treating diarrhea in companion animals
EP4125874A4 (en) *	2020-03-25	2024-05-01	SRI International	LIPOXYGENASE INHIBITORS
US11116737B1 (en)	2020-04-10	2021-09-14	University Of Georgia Research Foundation, Inc.	Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (ko)	2020-11-30	2022-06-07	(주)이노보테라퓨틱스	벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3896145A (en) *	1972-07-24	1975-07-22	Hoffmann La Roche	Carbazoles
CA1319886C (en) *	1987-02-03	1993-07-06	Alberto Ferro	Mixed micelle solutions

1998
- 1998-03-02 DZ DZ980089A patent/DZ2479A1/xx active
- 1998-04-30 TW TW087106689A patent/TW590773B/zh not_active IP Right Cessation
- 1998-05-01 KR KR1019997010252A patent/KR20010012300A/ko not_active Application Discontinuation
- 1998-05-01 BR BR9808720-7A patent/BR9808720A/pt not_active IP Right Cessation
- 1998-05-01 EA EA199900895A patent/EA003696B1/ru not_active IP Right Cessation
- 1998-05-01 HU HU0001286A patent/HUP0001286A3/hu unknown
- 1998-05-01 KR KR10-2003-7005258A patent/KR20040004406A/ko not_active Application Discontinuation
- 1998-05-01 NZ NZ500183A patent/NZ500183A/en unknown
- 1998-05-01 IL IL13257098A patent/IL132570A0/xx unknown
- 1998-05-01 PL PL98337003A patent/PL337003A1/xx unknown
- 1998-05-01 JP JP10547869A patent/JP2000513020A/ja active Pending
- 1998-05-01 AU AU69321/98A patent/AU6932198A/en not_active Abandoned
- 1998-05-01 WO PCT/IB1998/000662 patent/WO1998050033A1/en not_active Application Discontinuation
- 1998-05-01 CN CN98804845A patent/CN1255059A/zh active Pending
- 1998-05-01 SK SK1481-99A patent/SK148199A3/sk unknown
- 1998-05-01 ID IDP980651A patent/ID21311A/id unknown
- 1998-05-01 EP EP98915041A patent/EP0988034A1/en not_active Withdrawn
- 1998-05-01 CA CA002288759A patent/CA2288759A1/en not_active Abandoned
- 1998-05-01 YU YU55899A patent/YU55899A/sh unknown
- 1998-05-04 ZA ZA9803722A patent/ZA983722B/xx unknown
- 1998-05-04 TN TNTNSN98059A patent/TNSN98059A1/fr unknown
- 1998-05-04 UY UY24989A patent/UY24989A1/es not_active Application Discontinuation
- 1998-05-04 PE PE1998000335A patent/PE72599A1/es not_active Application Discontinuation
- 1998-05-04 AP APAP/P/1998/001234A patent/AP9801234A0/en unknown
- 1998-05-04 MA MA25059A patent/MA26491A1/fr unknown
- 1998-05-04 GT GT199800063A patent/GT199800063A/es unknown
- 1998-05-05 HR HR60/045,635A patent/HRP980244A2/hr not_active Application Discontinuation
- 1998-05-05 PA PA19988450601A patent/PA8450601A1/es unknown
- 1998-05-05 AR ARP980102089A patent/AR011726A1/es unknown
1999
- 1999-10-19 IS IS5220A patent/IS5220A/is unknown
- 1999-11-02 OA OA9900242A patent/OA11213A/en unknown
- 1999-11-03 BG BG103852A patent/BG103852A/xx unknown
- 1999-11-04 NO NO995389A patent/NO995389L/no not_active Application Discontinuation
2003
- 2003-04-09 AR ARP030101251A patent/AR039628A2/es unknown

Also Published As

Publication number	Publication date
EA003696B1 (ru)	2003-08-28
ID21311A (id)	1999-05-20
HUP0001286A2 (hu)	2000-11-28
DZ2479A1 (fr)	2003-02-01
AP9801234A0 (en)	1999-11-04
WO1998050033A1 (en)	1998-11-12
IL132570A0 (en)	2001-03-19
MA26491A1 (fr)	2004-12-20
HUP0001286A3 (en)	2000-12-28
PL337003A1 (en)	2000-07-31
JP2000513020A (ja)	2000-10-03
UY24989A1 (es)	2001-10-25
TNSN98059A1 (fr)	2005-03-15
OA11213A (en)	2003-07-14
IS5220A (is)	1999-10-19
BG103852A (en)	2000-06-30
PA8450601A1 (es)	2000-05-24
ZA983722B (en)	1999-11-04
PE72599A1 (es)	1999-08-12
NO995389L (no)	2000-01-04
EA199900895A1 (ru)	2000-06-26
KR20010012300A (ko)	2001-02-15
NO995389D0 (no)	1999-11-04
AU6932198A (en)	1998-11-27
CN1255059A (zh)	2000-05-31
TW590773B (en)	2004-06-11
BR9808720A (pt)	2000-07-11
AR039628A2 (es)	2005-03-02
AR011726A1 (es)	2000-08-30
SK148199A3 (en)	2001-09-11
HRP980244A2 (en)	1999-02-28
EP0988034A1 (en)	2000-03-29
NZ500183A (en)	2002-04-26
CA2288759A1 (en)	1998-11-12
GT199800063A (es)	1999-10-26
KR20040004406A (ko)	2004-01-13

Similar Documents

Publication	Publication Date	Title
YU55899A (sh)	2003-08-29	Cox-2 selektivni karprofen za lečenje bola i zapaljenja kod pasa
Kirstein et al.	1986	Tumor necrosis factor induces synthesis of two proteins in human fibroblasts.
NO2006007I1 (no)	2006-08-14	(+)-(S)-2-(3-benzoylfenyl)-propionsyre-trometaminsalt(deksketoprofentrometamol)
MY106628A (en)	1995-06-30	Estrogen-containing active substance plaster
NZ330860A (en)	1999-11-29	Method of inhibiting photoaging of skin
DE69613840D1 (de)	2001-08-16	Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle
PT1039895E (pt)	2002-10-31	Utilizacao de acidos 3-benzoilfenilaceticos respectivos esteres ou amidas para o tratamento do glaucoma glc1a
DE59808545D1 (de)	2003-07-03	Mittel zur hormonalen kontrazeption
NO20002440D0 (no)	2000-05-11	Hydroksam- og karboksylsyrederivater med MMP- og TNF- inhiberende aktivitet
TR200103178T2 (tr)	2002-05-21	İntegrinlerin reseptörlere bağlanmasını engelleyen karboksilik asit türevleri.
ATE333874T1 (de)	2006-08-15	Konjugierte linolensäure zur behandlung von cyclooxygenase-2 vermittelten entzündungen und schmerzen
EP1098642A4 (en)	2004-08-18	METHODS OF TREATING MODULATED CONDITIONS WITH LACTOSYLCERAMIDE
DE60014369D1 (de)	2004-11-04	Propansäurederivate, die die bindung von integrinen an ihre rezeptoren behindern
Umemiya et al.	1997	Action mechanism of retinoid-synergistic dibenzodiazepines
MA26777A1 (fr)	2004-12-20	Inhibiteurs d'aminotransferase dependante d'aminoacide en chaine ramifiee et leur usage dans le traitement de la retinopathie diabetique.
IL143594A0 (en)	2002-04-21	Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
ZA978400B (en)	1998-03-26	Use of inhibitors of the activity of retinoic acid to promote healing.
Hirabayashi et al.	1999	7-Nitroindazole attenuates nitrotyrosine formation in the early phase of cerebral ischemia-reperfusion in mice
ATE372126T1 (de)	2007-09-15	Spüllösung und verfahren zur schmerzlinderung und entzündungshemmung
HUP0001097A2 (hu)	2000-09-28	COMT-inhibitorok alkalmazása cukorbetegséggel kapcsolatos érrendszeri rendellenességek megelőzésére alkalmas gyógyszerkészítmények előállítására
CO5021216A1 (es)	2001-03-27	Carprofeno selectivo para cox-2, para el tratamiento del dolor e inflamacion en perros
DE69719095D1 (de)	2003-03-20	Gallensauersälze mit physiologisch aktiven metalle und ihre verwendung zur therapeutischen behandlung
WO2001041771A3 (de)	2001-12-27	Acetylsalicylsäure enthaltendes transdermales system zur behandlung von migräne
FR2760363B1 (fr)	1999-12-17	Composition pour le traitement topique des affections de la peau et des phaneres
NO960866L (no)	1996-03-04	Fremgangsmåte til behandling av leversykdom og lignende indikasjoner med vasodilaterende midler